441 related articles for article (PubMed ID: 34062018)
1. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.
Sánchez-Velázquez A; Bauer-Alonso A; Estrach T; Vega-Díez D; Garcia-Muret P; Haya L; Peñate Y; Acebo E; Fernández de Misa R; Blanes M; Suh-Oh HJ; Izu R; Silva-Díaz E; Sarriugarte J; Román-Curto C; Botella-Estrada R; Mateu-Puchades A; Prieto-Torres L; Morillas V; Morillo M; Sánchez-Caminero P; Calzado L; Pérez-Ferriols A; Pérez A; Domínguez JD; Navedo M; Muniesa C; Combalia A; Arroyo-Andrés J; Descalzo MA; García-Doval I; Ortiz-Romero PL
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e624-e626. PubMed ID: 34062018
[No Abstract] [Full Text] [Related]
2. Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
[TBL] [Abstract][Full Text] [Related]
3. The First Year of the AEVD Primary Cutaneous Lymphoma Registry.
Peñate Y; Servitje O; Machan S; Fernández-de-Misa R; Estrach MT; Acebo E; Mitxelena J; Ramón MD; Flórez A; Blanes M; Morillo M; Medina S; Bassas J; Zayas A; Espinosa P; Pérez A; Gónzalez-Romero N; Domínguez JD; Muniesa C; López Robles J; Combalia A; Yanguas I; Suh H; Polo-Rodríguez I; Bielsa I; Mateu A; Ferrer B; Descalzo MA; García-Doval I; Ortiz-Romero PL
Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):610-616. PubMed ID: 29680323
[TBL] [Abstract][Full Text] [Related]
4. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
Geskin LJ; Kwinta BD; Garcia-Saleem TJ; Akilov OE; Enz PA; Guenova E; Ortiz-Romero PL; Papadavid E; Quaglino P; Rozati S; Stonesifer CJ; Burns A; Stringer WS; Tarin E; Scarisbrick JJ
J Am Acad Dermatol; 2023 Apr; 88(4):935-937. PubMed ID: 36375717
[No Abstract] [Full Text] [Related]
5. Changing incidence trends of cutaneous B-cell lymphoma.
Korgavkar K; Weinstock MA
J Invest Dermatol; 2014 Mar; 134(3):840-842. PubMed ID: 24037340
[No Abstract] [Full Text] [Related]
6. Management of primary cutaneous lymphomas during the COVID-19 pandemic.
Mateeva V; Patsatsi A
Clin Dermatol; 2021; 39(1):64-75. PubMed ID: 33972055
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological analysis of the Chilean national registry of cutaneous T-cell lymphomas, years 2006-2012.
Arellano J; Salinas MP; Araya MI
Med Clin (Barc); 2020 Mar; 154(6):236-237. PubMed ID: 30591280
[No Abstract] [Full Text] [Related]
8. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination.
Panou E; Nikolaou V; Marinos L; Kallambou S; Sidiropoulou P; Gerochristou M; Stratigos A
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e91-e93. PubMed ID: 34628691
[No Abstract] [Full Text] [Related]
9. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.
Brumfiel CM; Patel MH; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
Leuk Lymphoma; 2021 Oct; 62(10):2554-2555. PubMed ID: 33974494
[No Abstract] [Full Text] [Related]
10. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
Papadavid E; Scarisbrick J; Ortiz Romero P; Guaglino P; Vermeer M; Knobler R; Stadler R; Bagot M
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1633-1636. PubMed ID: 32416629
[No Abstract] [Full Text] [Related]
11. Cutaneous T-cell lymphoma. Preface.
Bagot M
Dermatol Clin; 2008 Jan; 26 Suppl 1():V. PubMed ID: 18405179
[No Abstract] [Full Text] [Related]
12. Regional incidences of adult T-cell leukemia/lymphoma with cutaneous involvement in Japan.
Hamada T; Nomura H; Iwatsuki K
J Dermatol; 2018 Jan; 45(1):58-63. PubMed ID: 29068084
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
Lessin SR
Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
[No Abstract] [Full Text] [Related]
14. [Malignant lymphoma of the skin--especially cutaneous T-cell lymphoma].
Nakajima H
Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(13):1336-8. PubMed ID: 2079742
[No Abstract] [Full Text] [Related]
15. Incidence of primary cutaneous T-cell lymphoma in Wales.
Abbott RA; Aldridge C; Dojcinov S; Piguet V
Br J Dermatol; 2013 Dec; 169(6):1366-7. PubMed ID: 23855741
[No Abstract] [Full Text] [Related]
16. Second neoplasms associated with primary cutaneous lymphomas.
Gómez Sánchez ME; Rodríguez Vázquez M; Mollejo Villanueva M
An Bras Dermatol; 2019; 94(6):759-761. PubMed ID: 31789255
[No Abstract] [Full Text] [Related]
17. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical features of patients diagnosed with cutaneous T-cell lymphomas in a Spanish tertiary care hospital.
Cieza-Díaz DE; Conde-Montero E; Menarguez-Palanca J; Longo-Imedio I
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e150-e153. PubMed ID: 27518589
[No Abstract] [Full Text] [Related]
20. Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.
Wu Y; Kang K; Sun X; Niu T; Zhao A
J Am Acad Dermatol; 2024 Feb; 90(2):e75-e78. PubMed ID: 37802184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
